Linlin Zhang, Ciai Lai, Yanhong Su, Huizhong Gan, Yongchun Li, Zhen Yang, Shan Xu, Fengying Gong, Ying Lv, Jingjun Li, Qin Fan
The Second School of Clinic Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510410, China.
Southern Medical University, Nanfang Hospital, Department of Ancient Traditional Chinese Medicine, Guangzhou 510610, China.
Evid Based Complement Alternat Med. 2022 Feb 8;2022:4093138. doi: 10.1155/2022/4093138. eCollection 2022.
Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental disorder with complex pathogenesis. Currently, the pathogenesis of ASD is not fully understood. Moreover, current treatments do not effectively alleviate the primary symptoms of ASD social disorder (SCDA). Jiawei Yinhuo Tang (JWYHT) is an improved version of the classic prescription Yinhuo Tang. Although this medication has been shown to improve social behavior in ASD patients, the mechanism by which it works remains unknown.
In this study, network pharmacology bioinformatics analysis was used to identify the key targets, biological functions, and signal pathways of JWYHT in SCDA. Then, molecular docking and molecular dynamic simulation were used to validate the activity and stability of the active ingredient and the target protein during the binding process.
The analysis identified 157 key targets and 9 core targets of JWYHT (including proto-oncogene (FOS), caspase 3 (CASP3), mitogen-activated protein kinase-3 (MAPK3), interleukin-6 (IL6), mitogen-activated protein kinase-1 (MAPK1), tumor necrosis factor (TNF), mitogen-activated protein kinase-8 (MAPK8), AKT serine/threonine kinase 1 (AKT1), and 5-hydroxytryptamine receptor 1B (5HT1B)) in SCDA. In addition, the Kyoto Encyclopedia of Gene and Genome results, as well as the staggering network analyses, revealed 20 biological processes and 20 signal pathways targeted by JWYHT in SCDA. Finally, molecular docking analysis was used to determine the binding activity of the main active components of JWYHT to the key targets. The binding activity and stability of methyl arachidonate and MAPK8 were demonstrated using molecular dynamics simulation.
This study demonstrates that JWYHT regulates neuronal development, synaptic transmission, intestinal and cerebral inflammatory response, and other processes in SCDA.
自闭症谱系障碍(ASD)是一种高度异质性的神经发育障碍,发病机制复杂。目前,ASD的发病机制尚未完全明确。此外,目前的治疗方法并不能有效缓解ASD社交障碍(SCDA)的主要症状。加味银火汤(JWYHT)是经典方剂银火汤的改良方。虽然该药物已被证明可改善ASD患者的社交行为,但其作用机制仍不清楚。
本研究采用网络药理学生物信息学分析方法,确定JWYHT在SCDA中的关键靶点、生物学功能和信号通路。然后,利用分子对接和分子动力学模拟验证活性成分与靶蛋白结合过程中的活性和稳定性。
分析确定了JWYHT在SCDA中的157个关键靶点和9个核心靶点(包括原癌基因(FOS)、半胱天冬酶3(CASP3)、丝裂原活化蛋白激酶-3(MAPK3)、白细胞介素-6(IL6)、丝裂原活化蛋白激酶-1(MAPK1)、肿瘤坏死因子(TNF)、丝裂原活化蛋白激酶-8(MAPK8)、AKT丝氨酸/苏氨酸激酶1(AKT1)和5-羟色胺受体1B(5HT1B))。此外,京都基因与基因组百科全书结果以及惊人网络分析显示,JWYHT在SCDA中靶向20个生物学过程和20条信号通路。最后,通过分子对接分析确定JWYHT主要活性成分与关键靶点的结合活性。利用分子动力学模拟证明了花生四烯酸甲酯与MAPK8的结合活性和稳定性。
本研究表明,JWYHT在SCDA中调节神经元发育、突触传递、肠道和脑部炎症反应等过程。